Potential oxidative stress related targets of mitochondria-focused therapy of PTSD

Post-traumatic stress disorder (PTSD) remains a highly prevalent, under-diagnosed, and under-treated psychiatric disorder that often deteriorates over time, and is highly comorbid with major depressive disorder, suicidality, and substance use disorder. Several biomarkers have been proposed but have...

Full description

Bibliographic Details
Main Authors: Hanna Kmita, Graziano Pinna, Volodymyr I. Lushchak
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2023.1266575/full
_version_ 1797628992628457472
author Hanna Kmita
Graziano Pinna
Graziano Pinna
Graziano Pinna
Volodymyr I. Lushchak
Volodymyr I. Lushchak
author_facet Hanna Kmita
Graziano Pinna
Graziano Pinna
Graziano Pinna
Volodymyr I. Lushchak
Volodymyr I. Lushchak
author_sort Hanna Kmita
collection DOAJ
description Post-traumatic stress disorder (PTSD) remains a highly prevalent, under-diagnosed, and under-treated psychiatric disorder that often deteriorates over time, and is highly comorbid with major depressive disorder, suicidality, and substance use disorder. Several biomarkers have been proposed but have yet to be implemented into clinical practice. Treatments, including selective serotonin reuptake inhibitors, are efficacious in only a small number of patients, which underscores the need to develop novel, efficient treatments. Mitochondrial dysfunction resulting from chronic oxidative stress has been linked with both altered neurotransmitter signaling and the inflammatory response. Hereinafter, we discuss mechanisms by which mitochondrial dysfunction may contribute to the development of PTSD symptoms, and how these may even increase PTSD susceptibility. We also highlight possible therapeutic targets to reduce oxidative stress to prevent or treat PTSD symptoms.
first_indexed 2024-03-11T10:46:58Z
format Article
id doaj.art-6c5b78487d5742a7839060c1bee2dcfe
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-03-11T10:46:58Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-6c5b78487d5742a7839060c1bee2dcfe2023-11-14T02:03:39ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2023-11-011410.3389/fphys.2023.12665751266575Potential oxidative stress related targets of mitochondria-focused therapy of PTSDHanna Kmita0Graziano Pinna1Graziano Pinna2Graziano Pinna3Volodymyr I. Lushchak4Volodymyr I. Lushchak5Department of Bioenergetics, Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, Poznań, PolandPsychiatric Institute (SPHPI), Chicago, IL, United StatesUI Center on Depression and Resilience (UICDR), Chicago, IL, United StatesCenter for Alcohol Research in Epigenetics (CARE), Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, IL, United StatesDepartment of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, Ivano-Frankivsk, UkraineResearch and Development University, Ivano-Frankivsk, UkrainePost-traumatic stress disorder (PTSD) remains a highly prevalent, under-diagnosed, and under-treated psychiatric disorder that often deteriorates over time, and is highly comorbid with major depressive disorder, suicidality, and substance use disorder. Several biomarkers have been proposed but have yet to be implemented into clinical practice. Treatments, including selective serotonin reuptake inhibitors, are efficacious in only a small number of patients, which underscores the need to develop novel, efficient treatments. Mitochondrial dysfunction resulting from chronic oxidative stress has been linked with both altered neurotransmitter signaling and the inflammatory response. Hereinafter, we discuss mechanisms by which mitochondrial dysfunction may contribute to the development of PTSD symptoms, and how these may even increase PTSD susceptibility. We also highlight possible therapeutic targets to reduce oxidative stress to prevent or treat PTSD symptoms.https://www.frontiersin.org/articles/10.3389/fphys.2023.1266575/fullPTSDmitochondriareactive oxygen speciesmonoamine oxidasemitochondria-derived peptidesmitochondria-derived vesicles
spellingShingle Hanna Kmita
Graziano Pinna
Graziano Pinna
Graziano Pinna
Volodymyr I. Lushchak
Volodymyr I. Lushchak
Potential oxidative stress related targets of mitochondria-focused therapy of PTSD
Frontiers in Physiology
PTSD
mitochondria
reactive oxygen species
monoamine oxidase
mitochondria-derived peptides
mitochondria-derived vesicles
title Potential oxidative stress related targets of mitochondria-focused therapy of PTSD
title_full Potential oxidative stress related targets of mitochondria-focused therapy of PTSD
title_fullStr Potential oxidative stress related targets of mitochondria-focused therapy of PTSD
title_full_unstemmed Potential oxidative stress related targets of mitochondria-focused therapy of PTSD
title_short Potential oxidative stress related targets of mitochondria-focused therapy of PTSD
title_sort potential oxidative stress related targets of mitochondria focused therapy of ptsd
topic PTSD
mitochondria
reactive oxygen species
monoamine oxidase
mitochondria-derived peptides
mitochondria-derived vesicles
url https://www.frontiersin.org/articles/10.3389/fphys.2023.1266575/full
work_keys_str_mv AT hannakmita potentialoxidativestressrelatedtargetsofmitochondriafocusedtherapyofptsd
AT grazianopinna potentialoxidativestressrelatedtargetsofmitochondriafocusedtherapyofptsd
AT grazianopinna potentialoxidativestressrelatedtargetsofmitochondriafocusedtherapyofptsd
AT grazianopinna potentialoxidativestressrelatedtargetsofmitochondriafocusedtherapyofptsd
AT volodymyrilushchak potentialoxidativestressrelatedtargetsofmitochondriafocusedtherapyofptsd
AT volodymyrilushchak potentialoxidativestressrelatedtargetsofmitochondriafocusedtherapyofptsd